THE EFFECT OF THE PRESENTATION OF WRITTEN DRUG INFORMATION FOR PATIENT OF TYPE 2 DIABETES MELLITUS WITH HYPERTENSION
Diabetes Mellitus Type 2 (DMT2) is a chronic disorder that required adherence treatment to manage its progressivity. Type 2 DM can implicate into another disease, such as hypertension. A patient who suffer from DMT2 and hypertension, will consume at least two medication (polypharmacy). This pheno...
Saved in:
Main Author: | |
---|---|
Format: | Theses |
Language: | Indonesia |
Online Access: | https://digilib.itb.ac.id/gdl/view/47198 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Diabetes Mellitus Type 2 (DMT2) is a chronic disorder that required adherence treatment
to manage its progressivity. Type 2 DM can implicate into another disease, such as
hypertension. A patient who suffer from DMT2 and hypertension, will consume at least
two medication (polypharmacy). This phenomenon decreases patient’s adherence. There
are several methods to improve patient’s adherence, yet this study will try to develop an
alternative method which focus on the writing and the presentation of medication’s
information for patient of DMT2 with hypertension. This research is a case-control which
is done prospectively. This study conducted at four Primary Care in Bandung City with 60
Prolanis patients involved and divided into two groups, control group and intervention
group. To measure patient’s adherence, Fasting Blood Glucose, Two-Hour Post Prandial
Blood Glucose, and Morisky Medication Adherence Score-8 (MMAS-8) questionnaire was
used as parameter. The result showed that there were improvement in patient’s adherence
based on MMAS-8 score, that are in control group from 36,67% to 46,67% for patients
who have high adherence, for patient who have medium adherence showed no differences,
stayed at 43,33%, and from 20% to 10% for patients who have low adherence. While in the
intervention group, from 30% to 50% for patients who have high adherence, from 43,33%
to 40% for patients who have medium adherence, and from 26,67% to 10% for patients
who have low adherence. The result is analysed by paired t-test and independent t-test. The
result showed that there were significant differences (p=0,002 based on MMAS-8 score,
p=0,001 based on Fasting Blood Glucose, and p=0,048 based on Two-Hour Post Prandial
Blood Glucose), between both group before and after intervention. Therefore, medication’s
information leaf can be used as an alternative method to improve patient’s adherence.
|
---|